Related Experiment Video

Updated: Apr 11, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.5K

Splicing factor 2/alternative splicing factor contributes to extracellular signal‑regulated kinase activation in

Yawei Zhao1, Ting Zhu2, Xueying Zhang2

  • 1Laboratory of Cellular and Molecular Immunology, Henan University, Kaifeng, Henan 475001, P.R. China.

Molecular Medicine Reports
|May 29, 2015
PubMed

Insights

Splicing factor 2 (SF2/ASF) promotes hepatocellular carcinoma by increasing ERK pathway activation. Knocking down SF2 reduces ERK activation and enhances TNF-α-induced cell death, suggesting SF2 as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • Splicing factors, including SF2/ASF, are implicated in cancer development by regulating oncogenes and tumor suppressors.
  • SF2/ASF is a proto-oncogene linked to hepatocellular carcinoma (HCC) development, but its precise role requires elucidation.
  • Understanding SF2/ASF's molecular mechanisms in HCC is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the role of SF2/ASF in regulating signaling pathways in hepatocellular carcinoma cells.
  • To determine the effect of SF2/ASF knockdown on TNF-α-induced signaling and cell death.
  • To elucidate the molecular mechanism by which SF2/ASF influences ERK activation in HCC.

Main Methods:

  • Hepatoma cell lines were used to assess SF2/ASF knockdown effects.
  • Western blotting was employed to analyze the activation status of various signaling pathways (JNK, p38, IKK, ERK, Akt).
  • Tumor necrosis factor-α (TNF-α) stimulation and ERK activation blockade were utilized to study pathway modulation.

Main Results:

  • SF2/ASF knockdown did not affect TNF-α-induced JNK, p38, or IKK pathway activation.
  • SF2/ASF knockdown reduced basal and TNF-α-induced ERK activation without altering ERK protein levels.
  • SF2/ASF knockdown marginally enhanced TNF-α-induced cell death and partially suppressed IL-6 expression when combined with ERK blockade.

Conclusions:

  • SF2/ASF contributes to elevated ERK activation in hepatocellular carcinoma cells.
  • SF2/ASF likely modulates components downstream of growth factor receptors and upstream of ERK.
  • SF2/ASF represents a potential therapeutic target for hepatocellular carcinoma treatment.

More Related Videos

Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.7K
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.5K

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.8K
RNA Splicing01:32

RNA Splicing

20.5K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
27.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
8.5K